Form 4 for AVTX Avalo Therapeutics, Inc.
Accepted 2026-05-07 16:15:10 ET · period of report 2026-05-06 · accession 0001789335-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-07 16:15 | 2026-05-06 | AVTX | Chan Mitchell | Dir | S - Sale | $22.88 | -3,167 | 3,166 | -50% | -$72.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-06 | S | D | 3,167 | $22.88 | 3,166 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025. |